Compare LSTA & ATCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LSTA | ATCH |
|---|---|---|
| Founded | 1980 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Misc Health and Biotechnology Services | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.9M | 29.6M |
| IPO Year | 2000 | 2024 |
| Metric | LSTA | ATCH |
|---|---|---|
| Price | $3.37 | $0.19 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $15.00 | $1.00 |
| AVG Volume (30 Days) | 61.9K | ★ 1.4M |
| Earning Date | 05-11-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.42 | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | ★ $35,283,868.00 | N/A |
| Revenue This Year | N/A | $84.47 |
| Revenue Next Year | N/A | $39.32 |
| P/E Ratio | ★ N/A | $3.88 |
| Revenue Growth | ★ 56.90 | N/A |
| 52 Week Low | $1.81 | $0.14 |
| 52 Week High | $5.07 | $1.92 |
| Indicator | LSTA | ATCH |
|---|---|---|
| Relative Strength Index (RSI) | 43.36 | 41.77 |
| Support Level | $3.06 | $0.19 |
| Resistance Level | $3.41 | $0.22 |
| Average True Range (ATR) | 0.08 | 0.01 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 8.82 | 25.65 |
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.
AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.